
GMO, or Garlic Cookies (Cannabis flos Four 20 Pharma): lineage and two pharmacy positions
The GMO strain in Polish pharmacies has lineage from Chemdawg and Girl Scout Cookies, one producer, and two positions differing in declared potency. The profile composition is described by one source, and the abbreviation in the name has nothing to do with genetic modification.
| Strain card | GMO |
|---|---|
| Producers | Four 20 Pharma (1 pharmacy position) |
| Medical brand | the same as the producer |
| Alternative names | Garlic Cookies |
| Category according to sources | hybrid-indica / indica (sources inconsistent) |
| Leading terpene | myrcene |
| Other terpenes | farnesene humulene caryophyllene limonene |
| Lineage | established Chemdawg × Girl Scout Cookies |
| Source consistency | one source |
- Who supplies. Only Four 20 Pharma, so there is nothing to compare versions, and a supply break means no availability of this strain, not another version of it.
- Profile. Myrcene leads, alongside farnesene, humulene, caryophyllene, limonene. We do not provide percentage shares, as sources count them against different totals.
- Origin. Established lineage, parents are Chemdawg and Girl Scout Cookies.
- What is missing. The profile describes one source, so there is nothing to compare it with.
What is the GMO strain and where does it come from?
GMO is a cultivar resulting from the crossing of Chemdawg and Girl Scout Cookies strains. The abbreviation in the name has no connection to genetically modified organisms, and none of the sources on which this text is based provide an expansion of these three letters, so you will not find it here or in the tables below.
The line is attributed to Mamiko Seeds, and the garlic-scented phenotype was selected by a breeder known as Skunkmasterflex. This same pharmacy position is sometimes described under the second name, Garlic Cookies, and is signed by one of the Polish services cataloging pharmacy offers. The identity of both names was manually verified on the source page, and was not derived from the similarity of the writings, as the mere sound of the name in this cluster proves nothing.
Botanical classification differs in two sources: one describes this strain as a hybrid with indica dominance, the other simply as an indica. This discrepancy concerns the catalog label, not measurement, as neither of the two sources provides a laboratory or analysis certificate. The lineage remains the same in both versions and says more than the label: Chemdawg brings a fuel-spicy line, while Girl Scout Cookies brings a dessert line. The lineages of other cultivars from the Polish market are collected in a separate compilation maintained in the hub.
Which producers supply GMO to Polish pharmacies?
One. The flower with this name is supplied to Polish pharmacies exclusively by Four 20 Pharma, and cataloging services note two positions from this producer, differing in declared THC content. No other producer reports in this compilation any flower described by the name GMO or Garlic Cookies.
| Producer | Declared THC content given as a range | Availability noted at the time of the inventory | Name used by the source |
|---|---|---|---|
| Four 20 Pharma | 22.5-27.5% | none | GMO |
| Four 20 Pharma | 24.3-29.7% | high | GMO, in the second service Garlic Cookies |
The registered name of both positions carries a number within it, so we provide it without this element: Cannabis flos Four20Pharma. The value entered in the name is a declaration from the producer with a ten percent deviation in both directions, so quoted as a bare number it would promise precision that does not exist. Potency stands separately, in the column with the range, and should only be read that way. Apart from this declaration, the source does not note any difference between the two positions: the profile composition is entered for them identically, so they are distinguished only by the number in the registered name.
The table itself ages faster than the paragraph about lineage. One of the positions was listed at the time of the inventory as unavailable, the other as widely available, and such a state can reverse within a few weeks: it depends on the wholesale supply and whether the producer maintains permission for raw material admission. The current state is maintained exclusively in the cluster hub, along with numbers changing from month to month. We also separately explain how to read the declared potency of the flower.
What does this strain smell and taste like?
- farnesene farnesene
- humulene humulene
- caryophyllene caryophyllene
- limonene limonene
- myrcene myrcene (leading in the pharmacy list)
The source cataloging this position describes the aroma as musky, earthy, and herbal, while the cultivation description adds a garlic note, from which the second name derives. These are descriptive terms, written by people smelling the flower, and not results of measurement, so they are suitable for comparisons and nothing more.
The terpene profile composition describes this strain from one source and lists farnesene, humulene, caryophyllene, limonene, and myrcene. We do not transcribe shares, as the denominator is unknown: the total shares reported by Polish databases for the same positions range from just forty-six percent to eighty-three elsewhere, so the numbers from both places do not describe the same whole and cannot be compared. The aroma cannot be derived from this list: the source provides a description of the scent separately, without indicating which component is responsible for which note.
The order in this source places farnesene highest, while the list of pharmacy positions labels this strain with a single terpene, myrcene. This is not a measurement contradiction, but two different criteria: one organizes the composition within the profile, the other assigns a single scent label to the position. For both, we conduct separate discussions, for farnesene and for myrcene, as well as for humulene, caryophyllene, and limonene.
How long does it take for the strain to take effect and how long does the effect last?
This has not been measured for GMO. Neither the onset, peak, nor end of the episode has been described for this cultivar in the literature, so the only thing that can be honestly provided are ranges resulting from the route of administration. Physiology of absorption determines them, not the composition of this strain.
The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, as pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After ingestion | |
|---|---|---|
| First sensations | after a few minutes | from half an hour to two |
| Build-up | another dozen to thirty minutes | slowly, over several hours |
| Total duration | within two to four hours | after six, sometimes eight hours |
| Typical error | none | taking a dose after thirty minutes, which gives both doses at once |
Both pharmacy positions from this producer are distinguished solely by declared potency, so the above time ranges apply to them equally. The method of administration is determined by the attending physician, and the flower is dispensed by prescription.
What is known and what is not known about the effects of this strain?
A single terpene has been studied, not the strain. The evidence base for this project carries three studies on myrcene in mice, while for GMO itself, there is not a single study involving humans. Everything circulating about the effects of this strain comes from catalog descriptions or patient reports.
The catalog description assigns a balanced effect to this position. This is a label from the service, not a measurement result: there is no protocol, comparison group, or counted number of people behind it. The three studies below concern myrcene administered to animals in isolation, thus something different than the flower, in which myrcene coexists with other profile components. The closest to the realities of inhalation is the one from 2024, as the terpene was administered in vapor form, not by injection; however, it studied mice and a single compound, not the flower.
| Study | Model and route of administration | What was shown |
|---|---|---|
| Rao VS et al., 1990 Journal of Pharmacy and Pharmacology PMID:1983154 |
rodent (mouse) | Myrcene (10-40 mg/kg) reduced pain responses in mice in hot plate and writhing tests induced by acetic acid; the effect was reversed by naloxone and yohimbine, indicating involvement of alpha2-adrenergic receptors and release of endogenous opioids. |
| do Vale TG et al., 2002 Phytomedicine PMID:12587690 |
rodent (mouse, intraperitoneal administration) | Myrcene administered intraperitoneally (100-200 mg/kg) reduced the locomotor activity of mice in the open field test, prolonged sleep time induced by pentobarbital (by about 2.6 times at 200 mg/kg), and reduced the number of entries into the open arms of the elevated plus maze, which the authors described as a weak anxiogenic effect, not anxiolytic. |
| Wagner JK et al., 2024 NeuroSci PMID:39728677 |
rodent (mouse, vapor inhalation) | With short puffs mimicking inhalation in humans, beta-myrcene acted anxiolytically in the elevated plus maze in female mice, and in males only with a single puff. Unlike linalool, myrcene did not produce a synergistic effect with cannabidiol in either sex. |
In humans, it has not been shown that myrcene alone alleviates insomnia at doses typical for inhalation of the flower. The direction of the effect in rodents depends on the route of administration and sex: after intraperitoneal injection in 2002, a slightly anxiogenic effect was described, while after inhalation in 2024, an anxiolytic effect was noted in females. These two results do not cancel each other out, but show that the conclusion depends on conditions that no popular strain database provides.
What side effects have been reported after this strain?
None under this name. The reporting system links symptoms with the medicinal product and its batch, not with the cultivar, so there is simply no separate compilation for GMO. Instead of pretending, we provide below what is known about the raw material itself, and clearly mark the scope of this knowledge.
Reports of side effects are collected for the medicinal product with a batch number, not for the strain name, so the following pertains to cannabis flower as a group of raw materials. The most commonly reported are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety increasing with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for cannabis flower in Poland do not separate them by individual products.
No separate compilation of reports has been published for either of the two GMO positions, although they differ in declared potency. This does not mean that symptoms do not occur, only that no one counts them under this trade name.
What is known about the evaporation temperature of terpenes from this profile?
Less than popular tables suggest. The public database provides boiling temperatures along with pressure only for some components of this profile, does not provide it at all for one of them, and one value was measured almost in a vacuum. Compiling such numbers in one column compares measurements made under different conditions.
For myrcene, the database provides 166-167 °C at atmospheric pressure, for limonene about 176 °C, for caryophyllene 256-259 °C. Humulene has only a measurement at 3 mm Hg pressure, which is 99-100 °C under conditions close to vacuum, and farnesene has no boiling point at all in this database. Inserting the value for humulene next to the others gives a false number, not rounded.
Moreover, evaporation does not start only at boiling: the component also evaporates below this temperature, and the rate increases gradually with vapor pressure. The value set on the device describes the heating element or air, not the temperature of the flower itself, which cools during inhalation and heats unevenly. We do not provide any range here as recommended; the method of administration is determined by the attending physician. The flower sold over the counter, described in our cannabis flower category, is a different raw material than the pharmacy position described above.
Which strains are related to it?
| Strain | Common parent | Leading terpene | Producers |
|---|---|---|---|
| Electric Honeydew | Girl Scout Cookies | myrcene | Aurora |
| Balasa (Gorilla Girl) | Girl Scout Cookies | caryophyllene | Cosma |
| Tilray Sirius | Chemdawg | caryophyllene | Tilray |
Three, all present in Polish pharmacies: Electric Honeydew, Balasa (Gorilla Girl), and Tilray Sirius. The first two share the parent Girl Scout Cookies with GMO, while the third shares Chemdawg. The strain described here is the only one among them that connects both of these lines at once.
Electric Honeydew comes from Girl Scout Cookies crossed with 91 OG Krypt Melon, supplied by Aurora, and the pharmacy list labels it with the same leading terpene as GMO. Balasa, previously sold as Gorilla Girl, combines Gorilla Glue with Girl Scout Cookies and reaches pharmacies from the producer Cosma. Tilray Sirius originates from Chemdawg crossed with Alien Tech and is the only one of this trio that does not have the cookie line in its lineage.
Siblings are listed only where the parents are identified strains, not broad families of style. A common part of the name is not sufficient in either direction: two cultivars with similarly sounding names can have separate lineages, while strains named completely differently can be siblings because they share the same parent. The entire kinship graph for the Polish market is collected in the cluster hub. Each of these three strains, in fact, reaches pharmacies from a different producer than GMO, so genetic kinship does not align here with the division by suppliers.
Frequently asked questions about the GMO strain
Does the name GMO mean that the strain is genetically modified?
No. The abbreviation in the strain name has nothing to do with genetically modified organisms. The described lineage is a simple crossing of two cannabis strains, Chemdawg and Girl Scout Cookies, and the sources used in this text do not provide an expansion of these three letters.
Are GMO and Garlic Cookies the same strain?
Yes. The same pharmacy position from Four 20 Pharma is sometimes cataloged under the name Garlic Cookies. The identity of both names was manually verified on the source page, and was not derived from the similarity of the writings.
How many producers supply GMO to Polish pharmacies?
One: Four 20 Pharma. Two positions from the same producer are recorded, differing in declared potency, and their availability changes with wholesale deliveries.
Why do you provide THC content as a range, not as a single number?
Because the number in the registered name is a declaration from the producer with a ten percent deviation in both directions. Quoting it bare would promise accuracy that does not exist in this position.
Does the terpene profile of GMO confirm two sources?
No. The composition is described by one source and lists farnesene, humulene, caryophyllene, limonene, and myrcene. The second of the cataloging services lists this position without a terpene list.
Have studies been published for the GMO strain itself?
No involving humans. The evidence base for this project carries three studies concerning myrcene, all in mice, and none of them studied this strain or the flower as a whole.
Which strains are related to GMO?
Electric Honeydew, Balasa (Gorilla Girl), and Tilray Sirius. The first two share the parent Girl Scout Cookies, while the third shares the parent Chemdawg.
Cannabis flower is a pharmaceutical raw material dispensed by prescription in the Rpw category. The material is informational in nature and does not replace medical consultation. Editorial: ubucha.







